RAPT Therapeutics

Biotech & Life Sciences · San Francisco, United States · Founded 2013 · IPO 2019

RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative oral therapeutics aimed at targeting key drivers of the immune system. The company's mission is to transform the treatment of cancer and inflammatory diseases through cutting-edge science. RAPT Therapeutics primarily serves patients suffering from cancer and inflammatory conditions, offering them new hope through advanced medical treatments. Operating in the biopharmaceutical market, the company leverages its expertise in immunology to create therapies that intelligently target specific pathways within the immune system. The business model of RAPT Therapeutics revolves around research and development (R&D) of novel drug candidates, which are then advanced through clinical trials. The company generates revenue through partnerships, licensing agreements, and potential future sales of its proprietary drugs once they receive regulatory approval. RAPT Therapeutics also attracts investment opportunities, which help fund its ongoing R&D efforts and clinical trials. Key clients include healthcare providers, research institutions, and pharmaceutical companies interested in innovative treatments for cancer and inflammatory diseases. The company aims to improve and empower countless lives by offering effective and targeted therapeutic solutions. Keywords: biopharmaceutical, oral therapeutics, immune system, cancer treatment, inflammation, clinical trials, drug development, immunology, R&D, partnerships.

Valuation $1.53B

Revenue $1.5M

Total funding $100–500M

Power Law Unicorn$1–10B valuation tier

Featured in

News GSK buys 35Pharma for $950M to expand into pulmonary hypertension Feb 25, 2026

Investors

2 investors on RAPT Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Kleiner Perkins

The Column Group

Global footprint

Where RAPT Therapeutics has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States92.5%

🇬🇧 United Kingdom4.5%

🇿🇼 Zimbabwe1.5%

🇫🇷 France1.5%

4 countries shown

Web traffic by country

8.9K monthly visits
across markets

🇺🇸 United States44.9%

🇨🇦 Canada22.5%

🇮🇳 India19.1%

🇯🇵 Japan13.5%

Top 4 markets shown

Talent graph

The shape of RAPT Therapeutics's talent

Dealroom maps RAPT Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

38 team members profilednamed & role-tagged by Dealroom

123 employeestotal headcount

5 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock RAPT Therapeutics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$28M patent portfolio · 19 active families

Estimated portfolio value

$28M

1.8% of market cap · 7× smaller than top peer argenx ($198M)

19 active patent families

Where RAPT Therapeutics innovates AntagonistBiochemistryCCR4Cell biologyChemokine receptor activity

Where RAPT Therapeutics concentrates vs peers

Each axis is a top-10 topic across RAPT Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about RAPT Therapeutics

An AI-synthesized read of the highest-engagement posts about RAPT Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See RAPT Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles